Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002)

This publication has 16 references indexed in Scilit:

• In Vivo Selection of a Chromosomally Encodedβ-Lactamase Variant Conferring Ceftazidime Resistance in Klebsiellaoxytoca
  Antimicrobial Agents and Chemotherapy, 2003
• Antibiotic Resistance Among Gram-Negative Bacilli in US Intensive Care Units
  JAMA, 2003
• Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99)
  Diagnostic Microbiology and Infectious Disease, 2002
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998
  Journal of Antimicrobial Chemotherapy, 2000
• EXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMS
  Infectious Disease Clinics of North America, 1997
• Bases of variation in resistance to beta-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase
  Journal of Antimicrobial Chemotherapy, 1997
• A functional classification scheme for beta-lactamases and its correlation with molecular structure
  Antimicrobial Agents and Chemotherapy, 1995
• Origin and impact of plasmid-mediated extended-spectrum beta-lactamases
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• More extended-spectrum beta-lactamases
  Antimicrobial Agents and Chemotherapy, 1991